: Fetal alcohol spectrum disorders (FASD) are a significant global challenge characterized by complex diagnosis and research. The diagnostic process is complicated due to overlapping symptoms with other conditions, as well as factors such as maternal nutrition, socioeconomic status, and mental health, which can affect the severity of FASD traits differently in individuals. Risky drinking behaviors are prevalent in young adults, especially those aged 20-24, which coincides with high rates of unplanned pregnancies, increasing the risk of FASD. Specific subpopulations, such as children in care facilities and specialized clinical settings, face higher FASD prevalence. Preventing alcohol consumption during pregnancy is crucial for maternal and fetal well-being. Yet approximately 10% of women worldwide continue to drink during pregnancy, with notably high rates in the European Region. Young adults, especially in countries like Italy, continue to consume alcohol despite legal restrictions, mirroring the drinking patterns of men and raising concerns for fetal health and development. Research findings regarding alcohol’s risks during pregnancy vary, emphasizing the need for increased education on this issue. Ethylglucuronide (EtG) is a reliable biomarker for monitoring alcohol intake during pregnancy, suggesting regular urine examinations throughout each trimester. Proactive education campaigns, particularly in educational institutions, and establishing early diagnosis centers are recommended to address FASD effectively.

Linee guida italiane per la diagnosi e il trattamento dei disturbi dello spettro feto-alcolico: epidemiologia|Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology / Ceccanti, M.; Coriale, G.; Fiorentino, D.; Tarani, L.; Messina, M. P.; Vitali, M.; Fiore, M.; May, P. A.. - In: RIVISTA DI PSICHIATRIA. - ISSN 2038-2502. - 59:5(2024), pp. 259-268. [10.1708/4360.43516]

Linee guida italiane per la diagnosi e il trattamento dei disturbi dello spettro feto-alcolico: epidemiologia|Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology

Coriale G.;Fiorentino D.;Tarani L.;Messina M. P.;
2024

Abstract

: Fetal alcohol spectrum disorders (FASD) are a significant global challenge characterized by complex diagnosis and research. The diagnostic process is complicated due to overlapping symptoms with other conditions, as well as factors such as maternal nutrition, socioeconomic status, and mental health, which can affect the severity of FASD traits differently in individuals. Risky drinking behaviors are prevalent in young adults, especially those aged 20-24, which coincides with high rates of unplanned pregnancies, increasing the risk of FASD. Specific subpopulations, such as children in care facilities and specialized clinical settings, face higher FASD prevalence. Preventing alcohol consumption during pregnancy is crucial for maternal and fetal well-being. Yet approximately 10% of women worldwide continue to drink during pregnancy, with notably high rates in the European Region. Young adults, especially in countries like Italy, continue to consume alcohol despite legal restrictions, mirroring the drinking patterns of men and raising concerns for fetal health and development. Research findings regarding alcohol’s risks during pregnancy vary, emphasizing the need for increased education on this issue. Ethylglucuronide (EtG) is a reliable biomarker for monitoring alcohol intake during pregnancy, suggesting regular urine examinations throughout each trimester. Proactive education campaigns, particularly in educational institutions, and establishing early diagnosis centers are recommended to address FASD effectively.
2024
alcohol, disability, epidemiology, FASD, gestation, pregnancy.
01 Pubblicazione su rivista::01a Articolo in rivista
Linee guida italiane per la diagnosi e il trattamento dei disturbi dello spettro feto-alcolico: epidemiologia|Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: epidemiology / Ceccanti, M.; Coriale, G.; Fiorentino, D.; Tarani, L.; Messina, M. P.; Vitali, M.; Fiore, M.; May, P. A.. - In: RIVISTA DI PSICHIATRIA. - ISSN 2038-2502. - 59:5(2024), pp. 259-268. [10.1708/4360.43516]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1727257
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact